Introduction
Fulminant myocarditis is an uncommon, but severe cardiac inflammatory disease that can be fatal. The disease is characterized by a severe and sudden onset marked by a rapid progressive deterioration that can occur within 2 or 3 days. The use of extracorporeal membrane oxygenation (ECMO) is common; therefore, its application in fulminant myocarditis has also increased. Several case reports indicated that mechanical circulation support (MCS) devices, including ECMO, which provides full circulatory support with time for the heart to recover. However, to our knowledge, there are no reports of a patient with fulminant myocarditis who subsequently recovered cardiac function after long-term asystole.